|   | |
| Clinical data | |
|---|---|
| Trade names | Kenazepine | 
| Other names | Acetamide | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C19H16BrClFN3O2 | 
| Molar mass | 452.71 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
|   (what is this?) | |
Kenazepine is a benzodiazepine containing a functional alkylating moiety. [1] The chemical formula is C19H16BrClFN3O2. [2]
The compound functions as a research tool in pharmacology. It binds irreversibly and non-competitively to some brain benzodiazepine receptors and competitively to others, providing evidence for the existence of different receptor populations within the central nervous system. Kenazepine exhibits long-lasting anticonvulsant effects, likely due to its irreversible binding mechanism, and is used to study the heterogeneity and function of benzodiazepine receptors. [3]
Studies show that kenazepine provides a long-lasting protection against convulsions caused by pentylenetetrazole in vivo, suggesting a similar irreversible binding mechanism in the body. [2]
Kenazepine , a derivative of the benzodiazepine Ro 7/1986 has a bromoacetyl moiety that can react with binucleophiles such as SH and - NH2.